61-PANTI-HLA AND ANTI-MICA SPECIFIC ANTIBODIES DEVELOPED DURING THE FOLLOW-UP THREE YEARS CAN PREDICTIVE OF ACUTE REJECTION AND RENAL GRAFTFUNCTION.Jun He, Jian Quan Hou, Xiao Ni Yuan. Jiangsu Institute of Hematology, The First Affiliated Hospital ofSoochow University, Suzhou, Jiangsu, China.Aim: The purpose of this study was to detect dynamic <strong>for</strong> HLA and MICA could predict development ofacute rejection (AR) and kidney allograft function.Methods: 41 kidney transplant patients were tested <strong>for</strong> anti -HLA Abs and anti-MICA Abs. 37 patientswere screened using single-antigen beads to determine the HLA and MICA-specific antibody levels at 0,30, 90, 180, 360, 720 and 1080 days of posttransplantation. The patients and donors of HLA and MICAallele typing were determined by PCR-SSOP and DSA and NDSA.Results: 9 patients(21.95%) had pre-existing antibodies in 41 transplantation patients.among them 6patients had anti-MICA antibodies, 2 patients had anti-HLA antibodies, one patient had anti-MICAantibodies and anti-HLA antibodies.Patients with pre-existing anti-HLA Abs had higher acute rejection(66.7%) than patients with pre-existing anti-MICA Abs (33.3%)and patients without Abs (<strong>27</strong>.3%, (P
data suggests that DTT pretreatment of sera should be considered <strong>for</strong> all sera to minimize interference onSAB by Luminex.63-PPAINFUL FAMILY “MEMORIES”?Siva Kanangat 2 , Michele H. Prod 1 , Ina Kurbegovic 1 , Andre’s Jaramillo 1 . 1 Rush Medical Laboratories, RushUniversity Medical Center/HLA/Pathology, Chicago, IL, USA; 2 Pathology, St. Jude Children’s ResearchHospital, Memphis, TN, USA.Aim: Aim: To investigate two cases of acute renal transplant rejection despite total absence of HLAantibodies in recipients’ pretransplant sera and negative T/B cell cross match prior to transplantation.Methods: Patients/Donors: Two female living donor renal transplant recipients, a 62 year old female whoreceived kidney from her child, and a 58 year old female who received kidney from her husband, bothrejected the allograft shortly after transplantation. Alloimmune response analysis: Flow cytometry basedHLA antibody screening, Luminex-Microbead array based Labscreen PRA, Flow Cytometry based T and Bcell Cross match, and CDC-AHG Cross match were used <strong>for</strong> pretransplant HLA antibody detection. Posttransplant HLA antibodies were detected by single antigen microbead array (One Lambda).Results: Pretransplant sera were negative <strong>for</strong> both Class I and Class II antibodies and both Flow Cytometryand CDC-AHG cross matches using T and B cells prior to transplant were also negative in both patients.Post transplant serum from both patients had significant levels of multiple DSA as detected by Singleantigen bead assay.Conclusions: Both patients could have been exposed to their donor’s HLA prior to their transplants. Therecipient mother would have had exposure to the child’s paternally derived HLA during gestation.Similarly, the patient who received kidney from her husband would have had exposure to his HLA throughpregnancies. Although such exposure to <strong>for</strong>eign antigens during gestation could result in tolerization, itcould also result in alloimmunization. Both patients may have had memory cells to their donor’s HLA.Some long-lived plasma cells may not respond to certain immunosuppressants resulting in vigorousresponse upon contact with recall antigen after transplant. There<strong>for</strong>e, a pretransplant negative cross do notcompletely rule out the possibilities of an undesired anamnestic alloimmune response.64-PA NEW RECIPE FOR RENAL ALLOGRAFT BIOPSY – A NOVEL TOOL FOR THEDIAGNOSIS OF ABMR.Janette Kwok 1 , Gavin S.W. Chan 2 , M.F. Lam 3 , Tony Yan 1 , Lydia Tang 1 , K.M. Kwong 1 , K.W. Chan 2 , T.M.Chan 3 . 1 Tranpslantation and Immunogenetics, Queen Mary Hospital, Hong Kong SAR, China; 2 Pathology,The University of Hong Kong, Hong Kong SAR, China; 3 Medicine, The University of Hong Kong, HongKong SAR, China.Aim: Renal allograft biopsy has always been used <strong>for</strong> morphological confirmation of acute or chronicrejection affecting the transplanted kidney. The donor Human Leucocyte Antigen (HLA) phenotypes areoften not available in patients who underwent transplantation outside of Hong Kong. Yet this in<strong>for</strong>mation isessential <strong>for</strong> the determination of donor-specific antibodies (DSA) in the management of antibody mediatedrejection (ABMR), and in the selection of suitable donors <strong>for</strong> patients who require a re-transplant. Theobjective of this study is to determine mismatched donor HLA from allograft kidney biopsies in transplantrecipients with unknown donor HLA phenotype.Methods: Allograft kidney biopsies were obtained in 14 renal transplant recipients who presented withgraft dysfunction. Donor HLA phenotypes were known in 7 patients. DNA was extracted from freshallograft kidney specimens, and HLA typing was per<strong>for</strong>med with PCR-SSP and PCR-SSO.Results: The deduced donor HLA phenotypes were confirmed in 7 allograft renal biopsies, i.e. HLA resultsbeing the composite of both the recipient and the donor HLA phenotypes. This methodology was validatedin 7 allograft biopsies with known donor HLA phenotypes.Conclusions: This novel methodology overcomes the challenge with unknown donor HLA in kidneytransplant recipients, and is thus a useful tool <strong>for</strong> the detection of DSA, the management of ABMR, and theselection of suitable donors <strong>for</strong> re-transplantation.
- Page 1 and 2: Monday, September 27, 20102:00 PM -
- Page 3 and 4: 5-ORTWO CASES OF DONOR SPECIFIC ANT
- Page 5 and 6: Monday, September 27, 20102:00 PM -
- Page 7 and 8: Results: PHA-induced mRNA expressio
- Page 9 and 10: conjugated IgM (BD Biosciences), Ig
- Page 11 and 12: Methods: Peripheral blood and endom
- Page 13 and 14: Aim: NK cells have an established r
- Page 15 and 16: Methods: Sera (n=22) were tested fo
- Page 17 and 18: expression on lymphocytes, we hypot
- Page 19 and 20: Conclusions: Clean SA beads can eli
- Page 21 and 22: goal is to re-examine our previous
- Page 23 and 24: Aim: There is increasing evidence t
- Page 25 and 26: esult in poor graft survival. The g
- Page 27 and 28: Aim: Pronase treatment eliminates i
- Page 29 and 30: 34-PCLINICAL AND PATHOLOGICAL SIGNI
- Page 31 and 32: Nabil Mohsin, Isabelle G. Wood, Ind
- Page 33 and 34: donor/recipient pairs for transplan
- Page 35 and 36: and tested in the DynaChip assay fo
- Page 37 and 38: average difference between Ave and
- Page 39 and 40: Conclusions: The XM-One assay can b
- Page 41: 59-PCYTOTOXIC AND NON-CYTOTOXIC ANT
- Page 45 and 46: Bhavna Lavingia 1 , Chantale Lacell
- Page 47 and 48: ATG INTERFERNCE IN SINGLE ANTIGEN L
- Page 49 and 50: 75-PPREFORMED LOW REACTIVE ANTI-HLA
- Page 51 and 52: Sabarinathan Ramachandran 1 , Naohi
- Page 53 and 54: 83-PALLELIC DIVERSITY OF KIR2DL4 AN
- Page 55 and 56: São Paulo, Brazil; 3 Commissariat
- Page 57 and 58: 91-PCHARACTERIZATION OF COMMON AND
- Page 59 and 60: Conclusions: The extensive diversit
- Page 61 and 62: 99-PPOTENTIAL COMMON NOVEL ALLELES
- Page 63 and 64: 103-PTOWARDS A FUNCTIONAL HLA-DPB1
- Page 65 and 66: 107-PWHOLE GENOME AMPLIFICATION (WG
- Page 67 and 68: 111-PLOSS OF MISMATCHED HLA IN FAMI
- Page 69 and 70: 115-PDONOR EPITHELIAL CELL CHIMERIS
- Page 71 and 72: Caucasian patients. MRs vary signif
- Page 73 and 74: Results: We obtained the total No.
- Page 75 and 76: cord blood and platelet transfusion
- Page 77 and 78: 131-PASSOCIATION OF IL-2-330(G/T) W
- Page 79 and 80: Institute, Children’s Hospital Oa
- Page 81 and 82: Methods: To prove the robustness of
- Page 83 and 84: populations.We studied the involvem
- Page 85 and 86: amplicons generated from different
- Page 87 and 88: Results: The sequence of the unexpe
- Page 89 and 90: concentration of the Taq Polymerase
- Page 91 and 92: 160-PASSOCIATION OF HAPLOTYPES WITH
- Page 93 and 94:
164-PDETECTION OF A DE NOVO DONOR S
- Page 95 and 96:
168-PA NOVEL HLA-DQB1 ALLELE CONFIR
- Page 97 and 98:
172-PSCREENING FOR HLA-SPECIFIC ALL
- Page 99 and 100:
176-PIMPLEMENTATION OF THE WORLD HE
- Page 101 and 102:
epertoire of displayed ligands and
- Page 103 and 104:
mucosa. No other samples were avail
- Page 105 and 106:
Conclusions: In previously reported
- Page 107 and 108:
Conclusions: Our findings can demon
- Page 109 and 110:
Conclusions: In analyzing this data
- Page 111 and 112:
examined on microarrays from a huma
- Page 113 and 114:
Methods: Serial analysis of sera ob
- Page 115 and 116:
Conclusions: These new technologies
- Page 117 and 118:
allograft injury. Four of these 18
- Page 119 and 120:
A NOVEL HLA CLASS I SINGLE ANTIGEN
- Page 121 and 122:
Results: Approximately twice as man
- Page 123:
Methods: Molecular HLA typing was p